Brief: Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock
20/08/2026 04:06
BRIEF-Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock Aug 19 (Reuters) - Amylyx Pharmaceuticals, Inc. AMLX.O:
AMYLYX PHARMACEUTICALS ANNOUNCES PRICING OF AN UPSIZED $500 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK
AMYLYX PHARMACEUTICALS, - ANNOUNCES UPSIZED PUBLIC OFFERING OF 14,090,000 SHARES AT $35.50 PER SHARE
Source text: ID:nBw2h1CcNa
Further company coverage: AMLX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amylyx Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-LSI Industries, SiTime, Andersen Group
U.S. STOCKS ON THE MOVE-Apple, Hims & Hers Health, Sysco
U.S. STOCKS ON THE MOVE-Nordson, Nebius, Deere
Amylyx dips after increased $500 mln stock sale to fund blood sugar drug
Brief: Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock